Integrated mRNA-LNP Manufacturing Services Thousands of mRNA-based vaccines and therapies are in development, but progressing from discovery to clinical trials is far from simple.…
Integrated to Accelerate: Seamless End-to-End Biomanufacturing Speed, complexity, and quality—it’s no longer enough to pick two. In BioCina’s latest article, senior leaders share how the company’s…
Australia as a Strategic Gateway: The Economic and Regulatory Advantages of Clinical Manufacturing Down Under Biopharmaceutical companies are under mounting pressure to move faster, spend less, and ensure global compliance all without compromising innovation. This…
BioCina and NovaCina Merger Bolsters Global CDMO Industry Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a strategic merger that will create a powerful brand…
BioCina Expands Perth Facility to Provide Clinical Supplies Services Exciting news from NovaCina! We’ve installed and qualified a new Cytiva SA25 GMP isolator filling line to……
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine Adelaide, South Australia, October 10, 2024/– BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced…
EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment Adelaide, South Australia, September 25, 2024/ — BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO),…
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx Adelaide, South Australia, June 3, 2024/–…
BIO International Convention 2024 Our Business Development team is looking forward to attending BIO International Convention in San Diego, California, from June 3-6! Find…